The Combined Treatment with Ketogenic Diet and Metformin Slows Tumor Growth in Two Mouse Models of Triple Negative Breast Cancer

Author:

Schmidt Karen1,Thatcher Amber1,Grobe Albert2,Hicks Linda1,Gu Haiwei3,Sears Dorothy D.3,Ellies Lesley G.4,Kalachev Leonid5,Kroll Eugene6ORCID

Affiliation:

1. University of Montana Division of Biological Sciences

2. Silverlake Research Corporation

3. Arizona State University School of Life Sciences

4. University of California San Diego

5. University of Montana

6. University of Montana Missoula: University of Montana

Abstract

Abstract BACKGROUND Many tumors contain hypoxic microenvironments caused by inefficient tumor vascularization. Hypoxic tumors have been shown to resist conventional cancer therapies. Hypoxic cancer cells rely on glucose to meet their energetic and anabolic needs to fuel uncontrolled proliferation and metastasis. This glucose dependency is linked to a metabolic shift in response to hypoxic conditions. METHODS To leverage the glucose dependency of hypoxic tumor cells, we assessed the effects of a controlled reduction in systemic glucose by combining dietary carbohydrate restriction, using a ketogenic diet, with gluconeogenesis inhibition, using metformin, on two mouse models of triple-negative breast cancer (TNBC). RESULTS We confirmed that MET − 1 breast cancer cells require abnormally high glucose concentrations to survive in a hypoxic environment in vitro. Then, we showed that, compared to a ketogenic diet or metformin alone, animals treated with the combination regimen showed significantly lower tumor burden, higher tumor latency and slower tumor growth. As a result, lowering systemic glucose by this combined dietary and pharmacologic approach improved overall survival in our mouse model by 31 days, which is approximately equivalent to 3 human years. CONCLUSION This is the first preclinical study to demonstrate that reducing systemic glucose by combining a ketogenic diet and metformin significantly inhibits tumor proliferation and increases overall survival. Our findings suggest a possible treatment for a broad range of hypoxic and glycolytic tumor types, one that can also augment existing treatment options to improve patient outcomes.

Publisher

Research Square Platform LLC

Reference71 articles.

1. Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response;McKeown SR;BJR,2014

2. The hypoxic tumor microenvironment: A driving force for breast cancer progression;Semenza GL;Biochim et Biophys Acta - Mol Cell Res,2016

3. Tumor Hypoxia in Cancer Therapy;Brown JM;Methods Enzymol,2007

4. Hypoxic control of metastasis;Rankin EB;Science,2016

5. Li XF, Ma Y, Jiang H. Understanding hypoxia microenvironment of micrometastases. Journal of Solid Tumors [Internet]. 2012 [cited 2018 Oct 21];2(2). Available from: http://www.sciedu.ca/journal/index.php/jst/article/view/740.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3